Case number 1:21-cv-01006
Merck Sharp & Dohme Corp. v. Annora Pharma Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 10, 2022 | 27 | Consent Judgment (4) |
| Feb 10, 2022 | 27 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # (1) Consent Judgment)(nms) |
| Feb 10, 2022 | 26 | Consent Judgment (4) Docket Text: CONSENT JUDGMENT between Annora Pharma Private Limited, Hetero USA Inc., and Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/10/2022. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms) |
| Feb 10, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [26]. (nms) |
| Feb 9, 2022 | 25 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment between Plaintiff and Annora Pharma Private Limited, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 2/10/2022 (nms). |
| Dec 29, 2021 | 24 | Notice (Other) (2) Docket Text: NOTICE of SERVICE of Hetero's Paragraph 3 Initial Disclosures by Hetero USA Inc., (Capuzzi, Kevin) |
| Dec 29, 2021 | 23 | Notice (Other) (2) Docket Text: NOTICE of SERVICE of Annora's Paragraph 3 Initial Disclosures by Annora Pharma Private Limited (Capuzzi, Kevin) |
| Dec 23, 2021 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; (2) First Set of Interrogatories from Plaintiff Merck Sharp & Dohme Corp. to Defendants Annora Pharma Private Limited and Hetero USA Inc.; and (3) First Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants Annora Pharma Private Limited and Hetero USA Inc. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Dec 6, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The notices of service filed at D.I. 20 and D.I. 21 on 12/3/2021, have been removed from the docket. The filings were deficient in that they lacked reference to the MDL action they relate to. Defendants are to refile corrected notices of service and also file in the MDL action. (nms) |
| Dec 6, 2021 | 20 | Notice (Other) (2) Docket Text: NOTICE of SERVICE of Defendant Annora Pharma Private Ltd.'s Initial Disclosures Pursuant to FRCP Rule 26(a)(1), by Annora Pharma Private Limited. (Capuzzi, Kevin) Modified on 12/6/2021 (nms). |
| Dec 6, 2021 | 21 | Notice (Other) (2) Docket Text: NOTICE of Defendant Hetero USA Inc.'s Initial Disclosures Pursuant to FRCP Rule 26(a)(1) by Hetero USA Inc., (Capuzzi, Kevin) |
| Dec 3, 2021 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Dec 1, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-01006-RGA, 1:19-md-02902-RGA(Taylor, Daniel) |
| Nov 29, 2021 | 17 | Scheduling Order (8) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 4/22/2022. Amended Pleadings due by 4/22/2022. Fact Discovery completed by 7/15/2022. A Pretrial Conference is set for 5/12/2023, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 6/5/2023, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 11/29/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms) |
| Nov 29, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 11/30/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 11/29/2021. (nms) |
| Nov 24, 2021 | 16 | Proposed Order (8) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 11/24/2021 (nms). |
| Nov 1, 2021 | 15 | Answer to Counterclaim (6) Docket Text: ANSWER to [13] Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 27, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Zaiba Baig,Manish K. Mehta for Annora Pharma Private Limited and Hetero USA Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Oct 27, 2021 | 14 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 11/30/2021, at 11:00 AM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 10/27/2021. (nms) Modified on 11/29/2021 (nms). |
| Oct 11, 2021 | 13 | Answer to Complaint (21) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Hetero USA Inc.,, Annora Pharma Private Limited.(Capuzzi, Kevin) Modified on 10/12/2021 (nms). |
| Oct 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig, Esq., filed by Annora Pharma Private Limited, Hetero USA Inc., and [11] MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta, Esq., filed by Annora Pharma Private Limited, Hetero USA Inc.,. Signed by Judge Richard G. Andrews on 10/5/2021. (nms) |
| Oct 5, 2021 | 10 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Kevin M. Capuzzi on behalf of Annora Pharma Private Limited, Hetero USA Inc., (Capuzzi, Kevin) |
| Oct 5, 2021 | 11 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta, Esquire - filed by Annora Pharma Private Limited, Hetero USA Inc.,. (Capuzzi, Kevin) |
| Oct 5, 2021 | 12 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig, Esquire - filed by Annora Pharma Private Limited, Hetero USA Inc.,. (Capuzzi, Kevin) |
| Sep 9, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 574 in 19-md-2902-RGA; D.I. 9 in 21-cv-1006-RGA) STIPULATION TO EXTEND TIME the Deadline to Answer, Move or Otherwise Respond to the Complaint to October 11, 2021. Signed by Judge Richard G. Andrews on 9/9/2021. Associated Cases: 1:19-md-02902-RGA, 1:21-cv-01006-RGA(nms) |
| Sep 8, 2021 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the Deadline to Answer, Move or Otherwise Respond to the Complaint to October 11, 2021 - filed by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) |
| Jul 14, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 14, 2021 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Hetero USA Inc., waiver sent on 7/12/2021, answer due 9/10/2021. (Silver, Daniel) |
| Jul 14, 2021 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Annora Pharma Private Limited waiver sent on 7/12/2021, answer due 9/10/2021. (Silver, Daniel) |
| Jul 13, 2021 | N/A | Remark (0) Docket Text: Remark: MDL Panel has been notified of filing. (twk) |
| Jul 9, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Annora Pharma Private Limited, Hetero USA Inc., - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3654080.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
| Jul 9, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (twk) |
| Jul 9, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (twk) |
| Jul 9, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (twk) |
| Jul 9, 2021 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/25/2021. Date of Expiration of Patent: 11/24/2026 (May 24, 2027 - pediatric exclusivity expiration). Thirty Month Stay Deadline: 11/25/2023. (twk) |
| Jul 9, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jul 9, 2021 | 1 | Civil Cover Sheet (2) |
| Jul 9, 2021 | 1 | Exhibit A (18) |
| Jul 9, 2021 | 1 | Complaint* (1) |
